ARQT - Arcutis posts late-stage win for atopic dermatitis therapy in children
2023-09-19 08:22:32 ET
More on Arcutis
- Seeking Alpha’s Quant Rating on Arcutis Biotherapeutics
- Historical earnings data for Arcutis Biotherapeutics
- Arcutis: Zoryve - A Challenging Launch With Progress
- Arcutis Biotherapeutics: High OpEx And Crowded Markets Cloud Prospects
- Arcutis inks licensing deal to launch psoriasis cream in Asia
For further details see:
Arcutis posts late-stage win for atopic dermatitis therapy in children